Evolving application of biomimetic nanostructured hydroxyapatite

Nanotechnology, Science and Applications

Volumn 3, Issue 1, 2010, Pages 107-125

  Roveri, Norberto ^a   Iafisco, Michele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Biomaterials; Biomimetism; Drug delivery; Hydroxyapatite; Nanocrystals; Remineralization

Indexed keywords

ANTINEOPLASTIC AGENT; APATITE; BIOCERAMICS; BIOMATERIAL; BIOMIMETIC MATERIAL; BIOMORPHIC SILICON CARBIDE; BONE APATITE; BONE CEMENT; CALCIUM PHOSPHATE CERAMIC; CARBONATE HYDROXYAPATITE NANOCRYSTAL; CISPLATIN; COLLAGEN; COLLAGEN FIBRIL; CORALLINE APATITE; HEPARIN; HYDROXYAPATITE; MATRIX PROTEIN; NANOCOMPOSITE; NANOCRYSTAL; NANOHYDROXYAPATITE; NONCOLLAGENOUS PROTEIN; SILICON CARBIDE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ADSORPTION; BIOCOMPATIBILITY; BIOMIMETICS; BIOMINERALIZATION; BONE GRAFT; BONE GROWTH; BONE MINERAL; BONE MINERALIZATION; BONE POROSITY; BONE STRUCTURE; CANCELLOUS BONE; CARBONATION; CARBURIZATION; CEMENTUM; CHEMICAL COMPOSITION; CHEMICAL REACTION; CORTICAL BONE; CRYSTAL STRUCTURE; DENTAL CARE; DENTIN; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTROCHEMICAL ANALYSIS; ENAMEL; IMPLANT; IMPLANTABLE DRUG DELIVERY SYSTEM; NANOFABRICATION; OSTEOBLAST; OSTEOCLAST; OSTEON; OXIDATION; PARTICLE SIZE; PARTICLE SIZE DISTRIBUTION; PHOSPHATIZATION; POROSITY; PROTEIN ADSORPTION; PYROLYSIS; REVIEW; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TOOTH; TOOTH PULP; X RAY DIFFRACTION;

EID: 78650696552     PISSN: None     EISSN: 11778903     Source Type: Book Series    
DOI: 10.2147/NSA.S9038     Document Type: Review

References (179)

1. Boskey AL, Paschalis E. Bone Engineering. Davies JE, ed. Toronto, Canada: Em Squared, Inc.; 2000:44.
2. Cowles EA, DeRome ME, Pastizzo G, Brailey LL, Gronowicz GA. Mineralization and the expression of matrix proteins during in vivo bone development. Calcif Tissues Int. 1998;62(1):74-82.
3. Marks SC, Hermey DC. In: Bilezikian JP, Raisz LG, Rodan GA, editors. The Principles of Bone Biology. New York, NY: Academic Press; 1996:3.
4. Reddi AH. Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage. J Cell Biochem. 1994;56(2):192-195.
5. Urist MR. Bone: formation by autoinduction. Science. 1965;150(698):893-899.
6. Urist MR, Silverman BF, Buring K, Dubuc FL, Rosenberg J. The bone induction principle. Clin Orthop Relat Res. 1967;53:243-283.
7. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR. Osteonectin, a bone-specific protein linking mineral to collagen. Cell. 1981;26(1 Pt 1):99-105.
8. Wozney JM. The bone morphogenic protein family and osteogenesis. Mol Reprod Dev. 1992;32(2):160-167.
9. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21(2):115-137.
10. Weiner S, Wagner SD. The material bone: structure-mechanical function relations. Annu Rev Mater Sci. 1998;28(1):271-298.
11. Mann S. Biomineralization Principles and Concepts in Bioinorganic Materials Chemistry. Oxford, UK: Oxford University Press; 2001.
12. Palmer LC, Newcomb CJ, Kaltz SR, Spoerke ED, Stupp SI. Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel. Chem Rev. 2008;108(11):4754-4783.
13. Fernandez-Moran H, Engstrom A. Electron microscopy and X-ray diffraction of bone. Biochim Biophys Acta. 1957;23(2):260-264.
14. Traub W, Arad T, Weiner S. Three-dimensional ordered distribution of crystals in turkey tendon collagen fibers. Proc Natl Acad Sci U S A. 1989;86(24):9822-9826.
15. Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006;38(11):1310-1315.
16. Schmidt WJ. Über die Orientierung der Kristallite im Zahnschmelz. Naturwissenschaften. 1936;24(23):361.
17. Olszta MJ, Cheng X, Jee SS, et al. Bone structure and formation: a new perspective. Mat Sci Eng R Rep. 2007;58(3-5):77-116.
18. Burger C, Zhou HW, Wang H, et al. Lateral packing of mineral crystals in bone collagen fibrils. Biophys J. 2008;95(4):1985-1992.
19. Weiner S, Addadi L. Design strategies in mineralized biological materials. J Mater Chem. 1997;7(5):689-702.
20. Rho JY, Kuhn-Spearing L, Zioupos P. Mechanical properties and the hierarchical structure of bone. Med Eng Phys. 1998;20(2):92-102.
21. Robinson C, Kirkham J, Shore R. Dental Enamel Formation to Destruction. Boca Raton, FL: CRC Press; 1995.
22. Tamerler C, Sarikaya M. Molecular biomimetics: genetic synthesis, assembly, and formation of materials using peptides. MRS Bull. 2008;33(5):504-510.
23. Ten Cate AR. Oral Histology. Development, Structure, and Function. 4th ed. St. Louis, MO: Mosby; 1994.
24. White SN, Luo W, Paine ML, Fong H, Sarikaya M, Snead ML. Biological organization of hydroxyapatite crystallites into a fibrous continuum toughens and controls anisotropy in human enamel. J Dent Res. 2001;80(1):321-326.
25. Imbeni V, Kruzic JJ, Marshall GW, Marshall SJ, Ritchie RO. The dentin-enamel junction and the fracture of human teeth. Nat Mater. 2005;4(3):229-232.
26. Paine ML, White SN, Luo W, Fong H, Sarikaya M, Snead ML. Regulated gene expression dictates enamel structure and tooth function. Matrix Biol. 2001;20(5-6):273-292.
27. Wen HB, Moradian-Oldak J, Fincham AG. Dose-dependent modulation of octacalcium phosphate crystal habit by amelogenins. J Dent Res. 2000;79(11):1902-1906.
28. Lowestan HA, Weiner S. On Biomineralization. New York, NY: Oxford University Press; 1989.
29. Wang RZ, Weiner S. Strain-structure relations in human teeth using Moiré fringes. J Biomech. 1998;31(2):135-141.
30. Whittaker DK. Structural variations in the surface zone of human tooth enamel observed by scanning electron microscopy. Arch Oral Biol. 1982;27(5):383-392.
31. Boyde A. Handbook of Microscopic Anatomy. Oksche A, Vollrath V, editors. Berlin, Germany: Springer-Verlag; 1989.
32. Kodaka T, Nakajima F, Higashi S. Structure of the so-called 'prismless' enamel in human deciduous teeth. Caries Res. 1989;23(5):290-296.
33. Garant P. Oral Cells and Tissues. Chicago, IL: Quintessence Publishing Co., Inc.; 2003.
34. LeGeros RZ. Calcium phosphate-based osteoinductive materials. Chem Rev. 2008;108(11):4742-4753.
35. de Jong WF. The mineral substance in bone. Rec Trav Chim Pays-Bas. 1926;45:445-448.
36. Beevers CA, McIntyre DB. The atomic structure of fluorapatite and its relation to that of tooth and bone mineral. Mineral Mag. 1946;27:254-259.
37. McConnell D. The crystal chemistry of carbonate apatities and their relationship to the composition of calcified tissues. J Dent Res. 1952;31(1):53-63.
38. Kay MI, Young RA, Posner AS. Crystal structure of hydroxyapatite. Nature. 1964;204:1050-1052.
39. LeGeros RZ, LeGeros JP, Trautz OR, Klein E. Spectral properties of carbonate in carbonate-containing apatites. Dev Appl Spectrosc. 1970;7B:3.
40. LeGeros RZ, LeGeros JP, Trautz OR, Shirra WP. Conversion of monetite, CaHPO4, to apatites: effects of carbonate on the crystallinity and the morphology of the apatite crystallites. Adv X-ray Anal. 1971;14:57-66.
41. LeGeros RZ, Silverstone LM, Daculsi G, Kerebel LM. In vitro caries-like lesion formation in F-containing tooth enamel. J Dent Res. 1983;62(2):138-144.
42. LeGeros RZ, Trautz OR, LeGeros JP, Klein E, Shirra WP. Apatite crystallites: effects of carbonate on morphology. Science. 1967;155(3768):1409-1411.
43. LeGeros RZ. Apatites in biological systems. Prog Crystal Growth Charact. 1981;4:1-45.
44. Elliott JC. Structure and Chemistry of Apatites and Other Calcium Orthophosphates. Amsterdam, The Netherlands: Elsevier; 1994.
45. Rey C, Renugopalakrishnan V, Collins B, Glimcher MJ. Fourier transform infrared spectroscopic study of the carbonate ions in bone mineral during aging. Calcif Tissue Int. 1991;49(4):251-258.
46. Elliott JC, Holcomb DW, Young RA. Infrared determination of the degree of substitution of hydroxyl by carbonate ions in human dental enamel. Calcif Tissue Int. 1985;37(4):372-375.
47. Eichert D, Drouet C, Sfihia H, Rey C, Combes C. Nanocrystalline apatite-based biomaterials: synthesis, processing and characterization. In: Kendall JB, editor. Biomaterials Research Advances. New York, NY: Nova Science Publishers; 2010:93-143.
48. LeGeros RZ. Calcium Phosphates in Oral Biology and Medicine. New York, NY: Karger; 1991.
49. Dorozhkin SV, Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed Engl. 2002;41(17):3130-3146.
50. Daculsi G, Bouler JM, LeGeros RZ. Adaptive crystal formation in normal and pathological calcifications in synthetic calcium phosphate and related biomaterials. Int Rev Cytol. 1997;172:129-191.
51. Dorozhkin SV. Nanosized and nanocrystalline calcium orthophosphates. Acta Biomater. 2010;6(3):715-734.
52. Schmidt HK. Nanoparticles for ceramic and nanocomposite processing. Mol Cryst Liq Cryst. 2000;353:165-179.
53. Cushing BL, Kolesnichenko VL, O'Connor CJ. Recent advances in the liquidphase syntheses of inorganic nanoparticles. Chem Rev. 2004;104(9):3893-3946.
54. Wang X, Zhuang J, Peng Q, Li Y. A general strategy for nanocrystal synthesis. Nature. 2005;437(7055):121-124.
55. Mao Y, Park TJ, Zhang F, Zhou H, Wong SS. Environmentally friendly methodologies of nanostructure synthesis. Small. 2007;3(7):1122-1139.
56. Wang J, Shaw LL. Morphology-enhanced low-temperature sintering of nanocrystalline hydroxyapatite. Adv Mater. 2007;19(17):2364-2369.
57. Huang J, Best SM, Bonfield W, et al. In vitro assessment of the biological response to nano-sized hydroxyapatite. J Mater Sci Mater Med. 2004;15(4):441-445.
58. Liou SC, Chen SY, Lee HY, Bow JS. Structural characterization of nano-sized calcium deficient apatite powders. Biomaterials. 2004;25(2):189-196.
59. Ganesan K, Epple M. Calcium phosphate nanoparticles as nuclei for the preparation of colloidal calcium phytate. New J Chem. 2008;32(8):1326-1330.
60. Zhang Y, Lu J. A simple method to tailor spherical nanocrystal hydroxyapatite at low temperature. J Nanopart Res. 2007;9(4):589-594.
61. Sun W, Chu C, Wang J, Zhao H. Comparison of periodontal ligament cells responses to dense and nanophase hydroxyapatite. J Mater Sci Mater Med. 2007;18(5):677-683.
62. Chai CS, Ben-Nissan B. Bioactive nanocrystalline sol-gel hydroxyapatite coatings. J Mater Sci Mater Med. 1999;10(8):465-469.
63. Ben-Nissan B, Choi AH. Sol-gel production of bioactive nanocoatings for medical applications. Part 1. An introduction. Nanomedicine (Lond). 2006;1(3):311-319.
64. Choi AH, Ben-Nissan B. Sol-gel production of bioactive nanocoatings for medical applications. Part 2. Current research and development. Nanomedicine (Lond). 2007;2(1):51-61.
65. Rusu VM, Ng CH, Wilke M, Tiersch B, Fratzl P, Peter MG. Size-controlled hydroxyapatite nanoparticles as self-organized organic-inorganic composite materials. Biomaterials. 2005;26(26):5414-5426.
66. López-Macipe A, Gómez-Morales J, Rodríguez-Clemente R. Nanosized hydroxyapatite precipitation from homogeneous calcium/citrate/ phosphate solutions using microwave and conventional heating. Adv Mater. 1998;10(1):49-53.
67. Tas AC. Synthesis of biomimetic Ca-hydroxyapatite powders at 37 degrees C in synthetic body fluids. Biomaterials. 2000;21(14):1429-1438.
68. Guo X, Gough JE, Xiao P, Liu J, Shen Z. Fabrication of nanostructured hydroxyapatite and analysis of human osteoblastic cellular response. J Biomed Mater Res A. 2007;82(4):1022-1032.
69. Chaudhry AA, Haque S, Kellici S, et al. Instant nano-hydroxyapatite: a continuous and rapid hydrothermal synthesis. Chem Commun (Camb). 2006;(21):2286-2288.
70. Suchanek WL, Shuk P, Byrappa K, Riman RE, Ten Huisen KS, Janas VF. Mechanochemical-hydrothermal synthesis of carbonated apatite powders at room temperature. Biomaterials. 2002;23(3):699-710.
71. Yeon KC, Wang J, Ng SC. Mechanochemical synthesis of nanocrystalline hydroxyapatite from CaO and CaHPO4. Biomaterials. 2001;22(20):2705-2712.
72. Liu J, Li K, Wang H, Zhu M, Xu H, Yan H. Self-assembly of hydroxyapatite nanostructures by microwave irradiation. Nanotechnology. 2005;16(1):82-87.
73. Rameshbabu N, Rao KP, Kumar TSS. Accelerated microwave processing of nanocrystalline hydroxyapatite. J Mater Sci. 2005;40(23):6319-6323.
74. Siva Rama Krishna D, Siddharthan A, Seshadri SK, Sampath Kumar TS. A novel route for synthesis of nanocrystalline hydroxyapatite from eggshell waste. J Mater Sci Mater Med. 2007;18(9):1735-1743.
75. Iafisco M, Gomez Morales J, Hernandez-Hernandez MA, Garcia Ruiz JM, Roveri N. Biomimetic carbonate-hydroxyapatite nanocrystals prepared by vapor diffusion. Adv Eng Mater. 2010;12(7):B218-B223.
76. Iafisco M, Marchetti M, Gomez Morales J, Hernandez-Hernandez MA, Garcia Ruiz JM, Roveri N. Silica gel template for calcium phosphates crystallization. Cryst Growth Des. 2009;9(11):4912-4921.
77. Phillips MJ, Darr JA, Luklinska ZB, Rehman I. Synthesis and characterization of nanobiomaterials with potential osteological applications. J Mater Sci Mater Med. 2003;14(10):875-882.
78. Layrolle P, Lebugle A. Characterization and reactivity of nanosized calcium phosphate prepared in anhydrous ethanol. Chem Mater. 1994;6(11):1996-2004.
79. Ferraz MP, Monteiro FJ, Manuel CM. Hydroxyapatite nanoparticles: a review of preparation methodologies. J Appl Biomater Biomech. 2004;2:74-80.
80. Ye F, Guo H, Zhang H. Biomimetic synthesis of oriented hydroxyapatite mediated by nonionic surfactants. Nanotechnology. 2008;19(24):245605. Doi: 10.1088/0957-4484/19/24/245605.
81. Koutsopoulos S. Synthesis and characterization of hydroxyapatite crystals: a review study on the analytical methods. J Biomed Mater Res. 2002;62(4):600-612.
82. Tampieri A, Celotti G, Landi E. From biomimetic apatites to biologically inspired composites. Anal Bioanal Chem. 2005;381(3):568-576.
83. Roveri N, Palazzo B, Iafisco M. The role of biomimetism in developing nanostructured inorganic matrices for drug delivery. Expert Opin Drug Deliv. 2008;5(8):861-877.
84. Cai Y, Tang R. Calcium phosphate nanoparticles in biomineralization and biomaterials. J Mater Chem. 2008;18(32):3775-3787.
85. Ingert D, Pileni MP. Limitations in producing nanocrystals using reverse micelles as nanoreactors. Adv Funct Mater. 2001;11(2):136-139.
86. Wong KKW, Mann S. Biomimetic synthesis of cadmium sulfide-ferritin nanocomposites. Adv Mater. 1996;8(11):928-932.
87. Douglas T, Young M. Host-guest encapsulation of materials by assembled virus protein cages. Nature. 1998;393(6681):152-155.
88. Baral S, Schoen P. Silica-deposited phospholipid tubules as a precursor to hollow submicron-diameter silica cylinders. Chem Mater. 1993;5(2):145-147.
89. Stupp SI, Braun PV. Molecular manipulation of microstructures: biomaterials, ceramics, and semiconductors. Science. 1997;277(5330):1242-1248.
90. Paul W, Sharma CP. Nanoceramic matrices: biomedical applications. Am J Biochem Biotechnol. 2006;2(2):41-48.
91. Constantz BR, Ison IC, Fulmer MT, et al. Skeletal repair by in situ formation of the mineral phase of bone. Science. 1995;267(5205):1796-1799.
92. Brown WE, Chow LC. A new calcium phosphate setting cement. J Dent Res. 1983;62:672.
93. Ginebra MP, Driessens FC, Planell JA. Effect of the particle size on the micro and nanostructural features of a calcium phosphate cement: a kinetic analysis. Biomaterials. 2004;25(17):3453-3462.
94. Han Y, Li S, Wang X, Chen X. Synthesis and sintering of nanocrystalline hydroxyapatite powders by citric acid sol-gel combustion method. Mater Res Bull. 2004;39(1):25-32.
95. Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements as bone drug delivery systems: a review. J Control Release. 2006;113(2):102-110.
96. Rueger JM. Bone substitution materials. Current status and prospects. Orthopade. 1998;27(2):72-79.
97. Cui FZ, Li Y, Ge J. Self-assembly of mineralized collagen composites. Mater Sci Eng R Rep. 2007;57(1-6):1-27.
98. Zhang Y, Zhang M. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. J Biomed Mater Res. 2002;62(3):378-386.
99. Shirkhanzadeh M, Azadegan M. Formation of carbonate apatite on calcium phosphate coatings containing silver ions. J Mater Sci Mater Med. 1998;9(7):385-391.
100. Yoon BH, Kim HW, Lee SH, et al. Stability and cellular responses to fluorapatite-collagen composites. Biomaterials. 2005;26(16):2957-2963.
101. Guo H, Khor KA, Boey YC, Miao X. Laminated and functionally graded hydroxyapatite/yttria stabilized tetragonal zirconia composites fabricated by spark plasma sintering. Biomaterials. 2003;24(4):667-675.
102. Wei G, Ma PX. Structure and properties of nano-hydroxyapatite/ polymer composite scaffolds for bone tissue engineering. Biomaterials. 2004;25(19):4749-4757.
103. Clemens JA, Klein CP, Vriesde RC, Rozing PM, de Groot K. Healing of large (2 mm) gaps around calcium phosphate-coated bone implants: a study in goats with a follow-up of 6 months. J Biomed Mater Res. 1998;40(3):341-349.
104. Gu YW, Khor KA, Cheang P. In vitro studies of plasma-sprayed hydroxyapatite/Ti-6Al-4V composite coatings in simulated body fluid (SBF). Biomaterials. 2003;24(9):1603-1611.
105. Bigi A, Boanini E, Bracci B, et al. Nanocrystalline hydroxyapatite coatings on titanium: a new fast biomimetic method. Biomaterials. 2005;26(19):4085-4089.
106. Rodríguez-Lorenzo LM, Vallet-Regí M, Ferreira JM. Fabrication of hydroxyapatite bodies by uniaxial pressing from a precipitated powder. Biomaterials. 2001;22(6):583-588.
107. Tampieri A, Celotti G, Sprio S, Delcogliano A, Franzese S. Porositygraded hydroxyapatite ceramics to replace natural bone. Biomaterials. 2001;22(11):1365-1370.
108. Tadic D, Beckmann F, Schwarz K, Epple M. A novel method to produce hydroxyapatite objects with interconnecting porosity that avoids sintering. Biomaterials. 2004;25(16):3335-3340.
109. Rodríguez-Lorenzo LM, Vallet-Regí M, Ferreira JM, Ginebra MP, Aparicio C, Planell JA. Hydroxyapatite ceramic bodies with tailored mechanical properties for different applications. J Biomed Mater Res. 2002;60(1):159-166.
110. Padilla S, Román J, Vallet-Regí M. Synthesis of porous hydroxyapatites by combination of gelcasting and foams burn out methods. J Mater Sci Mater Med. 2002;13(12):1193-1197.
111. Habraken WJ, Wolke JG, Jansen JA. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007;59(4-5):234-248.
112. Roy DM, Linnehan SK. Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange. Nature. 1974;247(438):220-222.
113. Battistella E, Mele S, Pietronave S, et al. Transformed cuttlefish bone scaffolds for bone tissue engineering. Adv Mater Res. 2010;89-91:47-52.
114. Vallet-Regì M, Ràmila A, del Real RP, Pèrez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater. 2001;13(2):308-331.
115. Ben-Nissan B. Natural bioceramics: from coral to bone and beyond. Curr Opin Solid State Mater Sci. 2003;7(4-5):283-288.
116. Tampieri A, Celotti G, Landi E, et al. Porous phosphate-gelatin composite as bone graft with drug delivery function. J Mater Sci Mater Med. 2003;14(7):623-627.
117. Ma XP. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev. 2008;60(2):184-198.
118. Palazzo B, Sidoti MC, Roveri N, et al. Controlled drug delivery from porous hydroxyapatite grafts: an experimental and theoretical approach. Mater Sci Eng C. 2005;25(2):207-213.
119. Peña J, Vallet-Regí M, San Román J. TiO2-polymer composites for biomedical applications. J Biomed Mater Res. 1997;35(1):129-134.
120. Wang M, Kokubo T, Bonfield W. Bioceramics. Oxford, UK: Pergamon; 1996.
121. Kikuchi M, Sato K, Suetsugu Y, Tanaka J. Bioceramics. New York: World Scientific; 1998.
122. Bakos D, Soldán M, Hernández-Fuentes I. Hydroxyapatite-collagenhyaluronic acid composite. Biomaterials. 1999;20(2):191-195.
123. Cherng A, Takagi S, Chow LC. Effects of hydroxypropyl methylcellulose and other gelling agents on the handling properties of calcium phosphate cement. J Biomed Mater Res. 1997;35(3):273-277.
124. Li X, Fan T, Liu Z, Ding J, Guo Q, Zhang D. Synthesis of hierarchical pore structure of biomorphic manganese oxide derived from woods. J Eur Ceram Soc. 2006;26(16):3657-3664.
125. Zimmerman AF, Palumbo G, Aust KT, Erb U. Mechanical properties of nickel silicon carbide nanocomposites. Mater Sci Eng A. 2002;328(1-2):137-146.
126. Singh M, Martinez-Fernandez J, de Arellano-Lopez AR. Environmentally conscious ceramics (ecoceramics) from natural wood precursors. Curr Opin Solid State Mater Sci. 2003;7(3):247-254.
127. Singh M, Salem JA. Mechanical properties and microstructure of biomorphic silicon carbide ceramics fabricated from wood precursors. J Eur Ceram Soc. 2002;22(14-15):2709-2717.
128. de Arellano-Lopez AR, Martinez-Fernandez J, Gonzalez P, Dominguez C, Fernandez-Quero V, Singh M. Biomorphic SiC: a new engineering ceramic material. Int J Appl Ceram Technol. 2004;1(1):56-67.
129. Varela-Feria FM, Martinez-Fernandez J, de Arellano-López AR, Singh M. Low density biomorphic silicon carbide: microstructure and mechanical properties. J Eur Ceram Soc. 2006;22(14-15):2719-2725.
130. Zhu S, Zhang D, Li Z, Furukawa H, Chen Z. Precision replication of hierarchical biological structures by metal oxides using a sonochemical method. Langmuir. 2008;24(12):6292-6299.
131. Burzyska L, Rudnik E, Koza J, Bła L, Szymaski W. Electrodeposition and heat treatment of nickel/silicon carbide composites. Surf Coatings Technol. 2008;202(12):2545-2556.
132. Socha RP, Nowak P, Laajalehto K, Väyrynen J. Particle-electrode surface interaction during nickel electrodeposition from suspensions containing SiC and SiO2 particles. Colloids Surf A Physicochem Eng Asp. 2004;235(1-3):45-55.
133. Lelli M, Foltran I, Foresti E, et al. Biomorphic silicon carbide coated with an electrodeposition of nanostructured hydroxyapatite/ collagen as biomimetic bone filler and scaffold. Adv Eng Mater. 2010;12(8):B348-B355.
134. Tampieri A, Sprio S, Ruffini A, Celotti G, Lesci IG, Roveri N. From wood to bone: multi-step process to convert wood hierarchical structures into biomimetic hydroxyapatite scaffolds for bone tissue engineering. J Mater Chem. 2009;19:4973-4980.
135. Park K. Controlled Drug Delivery: Challenges and Strategies. Washington (DC): American Chemical Society; 1997.
136. Breimer DD. Future challenges for drug delivery. J Control Release. 1999;62(1-2):3-6.
137. Juliano RL. Controlled Delivery of Drugs: and Overview and Prospectus. New York: Oxford University Press; 1990.
138. Brayden DJ. Controlled release technologies for drug delivery. Drug Discov Today. 2003;8(21):976-978.
139. Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine. 2005;1(1):22-30.
140. Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine. 2005;1(3):193-212.
141. Lin CC, Metters AT. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv Drug Deliv Rev. 2006;58(12-13):1379-1408.
142. Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. pH Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms. Pharm Res. 2005;22(7):1129-1141.
143. Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev. 2006;58(3):387-401.
144. Szymura-Oleksiak J, Slosarczyk A, Cios A, et al. The kinetics of pentoxifylline release in vivo from drug-loaded hydroxyapatite implants. Ceram Int. 2001;27(7):767-772.
145. Dash AK, Cudworth GC 2nd. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods. 1998;40(1):1-12.
146. Palazzo B, Walsh D, Iafisco M, et al. Amino acid synergetic effect on structure, morphology and surface properties of biomimetic apatite nanocrystals. Acta Biomater. 2009;5(4):1241-1252.
147. Kandori K, Oda S, Fukusumi M, Morisada Y. Synthesis of positively charged calcium hydroxyapatite nano-crystals and their adsorption behavior of proteins. Colloids Surf B Biointerfaces. 2009;73(1):140-145.
148. Latour RA. Molecular simulation of protein-surface interactions: benefits, problems, solutions, and future directions. Biointerphases. 2008;3(3):FC2-FC12.
149. Hernández-Hernández A, Rodríguez-Navarro AB, Gómez-Morales J, Jiménez-Lopez C, Nys Y, García-Ruiz JM. Influence of model globular proteins with different isoelectric points on the precipitation of calcium carbonate. Cryst Growth Des. 2008;8(5):1495-1502.
150. Dee KC, Puleo DA, Bizios R. An Introduction to Tissue-Biomaterial Interactions. Hoboken: Wiley-Liss; 2003.
151. Liu TY, Chen SY, Liu DM, Liou SC. On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug delivery. J Control Release. 2005;107(1):112-121.
152. Pietronave S, Iafisco M, Locarno D, Rimondini L, Maria Prat M. Functionalized nanomaterials for diagnosis and therapy of cancer. J Appl Biomater Biomech. 2009;7(2):77-89.
153. Kondo A, Mihara J. Comparison of adsorption and conformation of hemoglobin and myoglobin on various inorganic ultrafine particles. J Colloid Interface Sci. 1996;177(1):214-221.
154. Boix T, Gómez-Morales J, Torrent-Burgués J, Monfort A, Puigdomènech P, Rodríguez-Clemente R. Adsorption of recombinant human bone morphogenetic protein rhBMP-2m onto hydroxyapatite. J Inorg Biochem. 2005;99(5):1043-1050.
155. Wassell DT, Hall RC, Embery G. Adsorption of bovine serum albumin onto hydroxyapatite. Biomaterials. 1995;16(9):697-702.
156. Barroug A, Fastrez J, Lemaitre J, Rouxhet P. Adsorption of succinylated lysozyme on hydroxyapatite. J Colloid Interface Sci. 1997;189(1):37-42.
157. Iafisco M, Palazzo B, Falini G, et al. Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate. Langmuir. 2008;24(9):4924-4930.
158. Iafisco M, Sabatino P, Lesci IG, Prat M, Rimondini L, Roveri N. Conformational modifications of serum albumins adsorbed on different kinds of biomimetic hydroxyapatite nanocrystals. Colloids Surf B Biointerfaces. 2010;81(1):274-284.
159. Epple M, Ganesan K, Heumann R, et al. Application of calcium phosphate nanoparticles in biomedicine. J Mater Chem. 2010;20(1):18-23.
160. Ewence AE, Bootman M, Roderick HL, et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res. 2008;103(5):e28-e34.
161. Doat A, Pelle F, Gardant N, Lebugle A. Synthesis of luminescent bioapatite nanoparticles for utilization as a biological probe. J Solid State Chem. 2004;177(4-5):1179-1187.
162. Padilla Mondejar S, Kovtun A, Epple M. Lanthanide-doped calcium phosphate nanoparticles with high internal crystallinity and with a shell of DNA as fluorescent probes in cell experiments. J Mater Chem. 2007;17(39):4153-4159.
163. Ramachandran R, Paul W, Sharma CP. Synthesis and characterization of PEGylated calcium phosphate nanoparticles for oral insulin delivery. J Biomed Mater Res B Appl Biomater. 2009;88(1):41-48.
164. Cheng X, Kuhn L. Chemotherapy drug delivery from calcium phosphate nanoparticles. Int J Nanomedicine. 2007;2(4):667-674.
165. Kester M, Heakal Y, Fox T, et al. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett. 2008;8(12):4116-4121.
166. Liu T, Tang A, Zhang G, et al. Calcium phosphate nanoparticles as a novel nonviral vector for efficient transfection of DNA in cancer gene therapy. Cancer Biother Radiopharm. 2005;20(2):141-149.
167. Palazzo B, Iafisco M, Laforgia M, et al. Biomimetic hydroxyapatitedrug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv Funct Mater. 2007;17(13):2180-2188.
168. Iafisco M, Palazzo B, Marchetti M, et al. Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals. J Mater Chem. 2009;19(44):8385-8392.
169. Fan Y, Duan K, Wang R. A composite coating by electrolysis-induced collagen self-assembly and calcium phosphate mineralization. Biomaterials. 2005;26(14):1623-1632.
170. Manara S, Paolucci F, Palazzo B, et al. Electrochemically assisted deposition of biomimetic hydroxyapatite-collagen coatings on titanium plate. Inorg Chim Acta. 2008;361(6):1634-1645.
171. Lu X, Zhao Z, Leng Y. Calcium phosphate crystal growth under controlled atmosphere in electrochemical deposition. J Cryst Growth. 2005;284(3-4):506-516.
172. Yousefpour M, Afshar A, Yang X, et al. Nano-crystalline growth of electrochemically deposited apatite coating on pure titanium. J Electroanal Chem. 2006;589(1):96-105.
173. Palazzo B, Manara S, Lelli M, et al. Electrochemically assisted deposition of nanostructured hydroxyapatite coatings with drugactivated surface. MC8: Advancing Materials by Chemical Design; 2007 Jul 2-5; University College London, UK.
174. Gazzaniga G, Roveri N, Rimondini L, Palazzo B, Iafisco M, Gualandi P. Biologically active nanoparticles of a carbonate-substituted hydroxyapatite process for their preparation and compositions incorporating the same. WO2007137606. 2007.
175. Roveri N, Palazzo B. Tissue, Cell and Organ Engineering. Weinheim: Wiley-VCH; 2006.
176. Roveri N, Battistella E, Bianchi CL, et al. Surface enamel remineralization: biomimetic apatite nanocrystals and fluoride ions different effects. J Nanomaterials. 2009;2009:746383. Doi:10.1155/2009/746383.
177. Rimondini L, Palazzo B, Iafisco M, et al. The remineralizing effect of carbonate-hydroxyapatite nanocrystals on dentine. Mater Sci Forum. 2007;539-543:602-605.
178. Roveri N, Battistella E, Foltran I, et al. Synthetic biomimetic carbonatehydroxyapatite nanocrystals for enamel remineralisation. Adv Mater Res. 2008;47-50:821-824.
179. Roveri N, Foresti E, Lelli M, Lesci IG. Recent advancements in preventing teeth health hazard: the daily use of hydroxyapatite instead of fluoride. Recent Pat Biomed Eng. 2009;2(3):197-215.